Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Comment by kornholeon Apr 19, 2002 2:14pm
172 Views
Post# 5027225

RE:Be realistic

RE:Be realisticThe American institutions scrutinize a companies past. There is little chance they will pour money into a recently bankrupt Canadian company that has an obscure past. RBM has no track record or service benchmark to compare against. The price of the unit has no bearing on the selection process. The accuracy threshold is also debatable. The risk/reward ratio may be fair at the 50 cent level. There is no Canadian or European market for the Anthrax application of this device. There is a very low probability that the USA will even consider a company of this nature. Everyone on this thread is blind to these facts. No one can challenge these points because they are reality.
Bullboard Posts